Drug
Soticlestat
Soticlestat: highest development phase Phase 1, developed by Takeda. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Takeda
Trials
| Drug | Phase | Indication |
|---|---|---|
| Soticlestat NCT05098054 | Phase 1 | Hepatic Impairment |
Latest
No recent events.
Follow Soticlestat on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.